PRISM HTLV-I/HTLV-II 6A53-48

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01 report with the FDA on 2010-11-16 for PRISM HTLV-I/HTLV-II 6A53-48 manufactured by Abbott Laboratories.

Event Text Entries

[1677714] The customer states that one patient sample generated repeat reactive results with the prism htlv-1/htlv-2 assay of s/co 1. 14, 1. 09 and 1. 28. The sample was non-reactive upon confirmatory testing. No suspect results were reported from the lab. No specific information was provided regarding the specimen or patient. There is no impact to patient management reported.
Patient Sequence No: 1, Text Type: D, B5


[8801815] (b)(4). No returns were made available from the customer site for this evaluation. The evaluation began with a review of the tracking of the 100 member human negative population for reagent lot number 88652hn00 for delta value, mean s/co (sample/cutoff) and maximum s/co. No run rule violations occurred indicating that this lot is not compromised regarding specificity. To evaluate the specificity performance of the reagent lot a total of eight replicates of an htlv specificity panel were analyzed on both sub-channels. All generated s/co results for each individual replicate were within specifications (less than 0. 80 s/co) and no false reactive results were obtained. Testing was performed on a retained kit of prism htlv-i/htlv-ii assay kit, list number 6a53-48, lot number 88652hn00. All generated data demonstrate that the performance of the prism htlv-i/htlv-ii assay kit, list number 6a53-48, lot number 88652hn00 is not compromised. A review of complaint tracking and trending metrics was performed and identified no adverse trends in conjunction with the complaint issue currently under evaluation. The abbott prism htlv-i/htlv-ii reagent, ln 6a53-48 package insert contains information to address the customer's current issue. Based on the current evaluation, it was determined that the prism htlv-i/htlv-ii reagent, list number 6a53-48, lot number 88652hn00, is performing acceptably. A product malfunction was not identified. Evaluation, method: review of complaint tracking and trending.
Patient Sequence No: 1, Text Type: N, H10


[8975058] (b)(4). This report is being filed on an international product, prism htlv-i/htlv-ii, list number 6a53 that has a similar product distributed in the u. S. , prism htlv-i/htlv-ii, list number 6e50. An investigation is in process. A follow-up report will be submitted when the investigation is complete.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1415939-2010-00534
MDR Report Key1900668
Report Source01
Date Received2010-11-16
Date of Report2010-11-03
Date Mfgr Received2010-11-22
Device Manufacturer Date2010-06-01
Date Added to Maude2011-05-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactNOEMI KONDOS RN, BSN
Manufacturer Street200 ABBOTT PARK ROAD DEPT. 09B9, AP50
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone8479375120
Manufacturer G1ABBOTT LABORATORIES
Manufacturer Street100 ABBOTT PARK ROAD
Manufacturer CityABBOTT PARK IL 60064350
Manufacturer CountryUS
Manufacturer Postal Code60064 3500
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePRISM HTLV-I/HTLV-II
Generic NameFOR DETECTION OF HTLV-I/ HTLV-II ANTIBODIES IN HUMAN SERUM OR PLASMA
Product CodeMTP
Date Received2010-11-16
Catalog Number6A53-48
Lot Number88652HN00
Device Expiration Date2011-08-26
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABBOTT LABORATORIES
Manufacturer Address100 ABBOTT PARK ROAD ABBOTT PARK IL 60064350 US 60064 3500


Patients

Patient NumberTreatmentOutcomeDate
10 2010-11-16

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.